193 related articles for article (PubMed ID: 12969089)
1. Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial.
Nista EC; Candelli M; Cremonini F; Cazzato IA; Di Caro S; Gabrielli M; Santarelli L; Zocco MA; Ojetti V; Carloni E; Cammarota G; Gasbarrini G; Gasbarrini A
Aliment Pharmacol Ther; 2003 Sep; 18(6):627-33. PubMed ID: 12969089
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection.
Wong WM; Gu Q; Lam SK; Fung FM; Lai KC; Hu WH; Yee YK; Chan CK; Xia HH; Yuen MF; Wong BC
Aliment Pharmacol Ther; 2003 Feb; 17(4):553-60. PubMed ID: 12622764
[TBL] [Abstract][Full Text] [Related]
3. Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled Trial.
Hsu PI; Tsai FW; Kao SS; Hsu WH; Cheng JS; Peng NJ; Tsai KW; Hu HM; Wang YK; Chuah SK; Chen A; Wu DC
Am J Gastroenterol; 2017 Sep; 112(9):1374-1381. PubMed ID: 28719592
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen.
Kahramanoğlu Aksoy E; Pirinçci Sapmaz F; Göktaş Z; Uzman M; Nazlıgül Y
Med Princ Pract; 2017; 26(6):523-529. PubMed ID: 29131124
[TBL] [Abstract][Full Text] [Related]
5. Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy'.
Perri F; Festa V; Merla A; Barberani F; Pilotto A; Andriulli A
Aliment Pharmacol Ther; 2003 Oct; 18(8):815-20. PubMed ID: 14535875
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 10-day levofloxacin bismuth-based quadruple therapy and levofloxacin-based triple therapy for Helicobacter pylori.
Wu TS; Hsu PI; Kuo CH; Hu HM; Wu IC; Wang SSW; Chen YH; Wu DC; Su WW; Kuo FC
J Dig Dis; 2017 Sep; 18(9):537-542. PubMed ID: 28644575
[TBL] [Abstract][Full Text] [Related]
7. A study of 4- and 7-day triple therapy with rabeprazole, high-dose levofloxacin and tinidazole rescue treatment for Helicobacter pylori eradication.
Giannini EG; Bilardi C; Dulbecco P; Mamone M; Santi ML; Testa R; Mansi C; Savarino V
Aliment Pharmacol Ther; 2006 Jan; 23(2):281-7. PubMed ID: 16393308
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments.
Gisbert JP; Romano M; Gravina AG; Solís-Muñoz P; Bermejo F; Molina-Infante J; Castro-Fernández M; Ortuño J; Lucendo AJ; Herranz M; Modolell I; Del Castillo F; Gómez J; Barrio J; Velayos B; Gómez B; Domínguez JL; Miranda A; Martorano M; Algaba A; Pabón M; Angueira T; Fernández-Salazar L; Federico A; Marín AC; McNicholl AG
Aliment Pharmacol Ther; 2015 Apr; 41(8):768-75. PubMed ID: 25703120
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of levofloxacin-based triple therapy as second-line Helicobacter pylori eradication].
Jung HS; Shim KN; Baik SJ; Na YJ; Kang MJ; Jung JM; Ha CY; Jung SA; Yoo K
Korean J Gastroenterol; 2008 May; 51(5):285-90. PubMed ID: 18516012
[TBL] [Abstract][Full Text] [Related]
10. Fourteen-day optimized levofloxacin-based therapy versus classical quadruple therapy for Helicobacter pylori treatment failures: a randomized clinical trial.
Cao Z; Chen Q; Zhang W; Liang X; Liao J; Liu W; Xiao S; Lu H
Scand J Gastroenterol; 2015; 50(10):1185-90. PubMed ID: 25881966
[TBL] [Abstract][Full Text] [Related]
11. A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication.
Zullo A; Hassan C; De Francesco V; Lorenzetti R; Marignani M; Angeletti S; Ierardi E; Morini S
Dig Liver Dis; 2003 Apr; 35(4):232-6. PubMed ID: 12801033
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection.
Cammarota G; Cianci R; Cannizzaro O; Cuoco L; Pirozzi G; Gasbarrini A; Armuzzi A; Zocco MA; Santarelli L; Arancio F; Gasbarrini G
Aliment Pharmacol Ther; 2000 Oct; 14(10):1339-43. PubMed ID: 11012480
[TBL] [Abstract][Full Text] [Related]
13. Ten-day Quadruple therapy comprising proton-pump inhibitor, bismuth, tetracycline, and levofloxacin achieves a high eradication rate for Helicobacter pylori infection after failure of sequential therapy.
Hsu PI; Chen WC; Tsay FW; Shih CA; Kao SS; Wang HM; Yu HC; Lai KH; Tseng HH; Peng NJ; Chen A; Kuo CH; Wu DC;
Helicobacter; 2014 Feb; 19(1):74-9. PubMed ID: 24033865
[TBL] [Abstract][Full Text] [Related]
14. Randomized Clinical Trial: Esomeprazole, Bismuth, Levofloxacin, and Amoxicillin or Cefuroxime as First-Line Eradication Regimens for Helicobacter pylori Infection.
Fu W; Song Z; Zhou L; Xue Y; Ding Y; Suo B; Tian X; Wang L
Dig Dis Sci; 2017 Jun; 62(6):1580-1589. PubMed ID: 28391418
[TBL] [Abstract][Full Text] [Related]
15. Can Helicobacter pylori eradication regimens be shortened in clinical practice? An open-label, randomized, pilot study of 4 and 7-day triple therapy with rabeprazole, high-dose levofloxacin, and tinidazole.
Giannini EG; Bilardi C; Dulbecco P; Mamone M; Santi ML; Testa R; Mansi C; Savarino V
J Clin Gastroenterol; 2006 Jul; 40(6):515-20. PubMed ID: 16825934
[TBL] [Abstract][Full Text] [Related]
16. Quadruple, sequential, and concomitant first-line therapies for H. pylori eradication: a prospective, randomized study.
De Francesco V; Pontone S; Bellesia A; Serviddio G; Panetta C; Palma R; Zullo A
Dig Liver Dis; 2018 Feb; 50(2):139-141. PubMed ID: 29089267
[TBL] [Abstract][Full Text] [Related]
17. Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection.
Gisbert JP; Molina-Infante J; Marin AC; Vinagre G; Barrio J; McNicholl AG
Scand J Gastroenterol; 2013 Jun; 48(6):652-6. PubMed ID: 23556551
[TBL] [Abstract][Full Text] [Related]
18. Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication.
Nista EC; Candelli M; Zocco MA; Cremonini F; Ojetti V; Finizio R; Spada C; Cammarota G; Gasbarrini G; Gasbarrini A
Am J Gastroenterol; 2006 Sep; 101(9):1985-90. PubMed ID: 16968503
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of two levofloxacin-containing second-line therapies for Helicobacter pylori: a pilot study.
Calhan T; Kahraman R; Sahin A; Senates E; Doganay HL; Kanat E; Ozdil K; Sokmen HM
Helicobacter; 2013 Oct; 18(5):378-83. PubMed ID: 23601026
[TBL] [Abstract][Full Text] [Related]
20. Quadruple rescue therapy for Helicobacter pylori infection after two treatment failures.
Hsu PI; Wu DC; Chen A; Peng NJ; Tseng HH; Tsay FW; Lo GH; Lu CY; Yu FJ; Lai KH
Eur J Clin Invest; 2008 Jun; 38(6):404-9. PubMed ID: 18435764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
